1. Home
  2. YMAB vs SGC Comparison

YMAB vs SGC Comparison

Compare YMAB & SGC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • YMAB
  • SGC
  • Stock Information
  • Founded
  • YMAB 2015
  • SGC 1920
  • Country
  • YMAB United States
  • SGC United States
  • Employees
  • YMAB N/A
  • SGC N/A
  • Industry
  • YMAB Biotechnology: Pharmaceutical Preparations
  • SGC Apparel
  • Sector
  • YMAB Health Care
  • SGC Consumer Discretionary
  • Exchange
  • YMAB Nasdaq
  • SGC Nasdaq
  • Market Cap
  • YMAB 192.4M
  • SGC 163.3M
  • IPO Year
  • YMAB 2018
  • SGC N/A
  • Fundamental
  • Price
  • YMAB $4.60
  • SGC $9.86
  • Analyst Decision
  • YMAB Buy
  • SGC Strong Buy
  • Analyst Count
  • YMAB 11
  • SGC 3
  • Target Price
  • YMAB $17.55
  • SGC $17.00
  • AVG Volume (30 Days)
  • YMAB 226.0K
  • SGC 48.8K
  • Earning Date
  • YMAB 05-13-2025
  • SGC 05-08-2025
  • Dividend Yield
  • YMAB N/A
  • SGC 5.66%
  • EPS Growth
  • YMAB N/A
  • SGC N/A
  • EPS
  • YMAB N/A
  • SGC 0.45
  • Revenue
  • YMAB $88,658,000.00
  • SGC $563,931,000.00
  • Revenue This Year
  • YMAB N/A
  • SGC $1.02
  • Revenue Next Year
  • YMAB $16.03
  • SGC $3.98
  • P/E Ratio
  • YMAB N/A
  • SGC $21.95
  • Revenue Growth
  • YMAB 4.92
  • SGC 2.28
  • 52 Week Low
  • YMAB $3.55
  • SGC $9.11
  • 52 Week High
  • YMAB $16.11
  • SGC $21.80
  • Technical
  • Relative Strength Index (RSI)
  • YMAB 56.43
  • SGC 43.41
  • Support Level
  • YMAB $3.99
  • SGC $9.63
  • Resistance Level
  • YMAB $5.00
  • SGC $10.02
  • Average True Range (ATR)
  • YMAB 0.35
  • SGC 0.37
  • MACD
  • YMAB 0.10
  • SGC 0.00
  • Stochastic Oscillator
  • YMAB 70.47
  • SGC 20.33

About YMAB Y-mAbs Therapeutics Inc.

Y-mAbs Therapeutics Inc is a commercial-stage biopharmaceutical company. It is mainly engaged in the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer. DANYELZA, is the first FDA-approved product of the company which is a recombinant humanized immunoglobulin G, subtype 1k, or IgG1k, monoclonal antibody or mAb that targets ganglioside GD2, which is expressed in various neuroectoderm-derived tumors and sarcomas.

About SGC Superior Group of Companies Inc.

Superior Group Of Companies Inc designs apparel products. The company's operating segment includes Branded Products; Healthcare Apparel and Contact Centers. It generates maximum revenue from the Branded Products segment. The Branded Products segment produce and sell customized merchandising solutions, promotional products and branded uniform programs to customers.

Share on Social Networks: